iridium has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Liu, C; Xiang, C; Xiang, J | 1 |
| Cui, D; Huang, P; Huang, W; Su, Y; Wang, D; Yan, D; Zhou, Y; Zhu, X | 1 |
2 other study(ies) available for iridium and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Enhancing the tumor cell selectivity of a rhodamine-decorated iridium(III) complex by conjugating with indomethacin for COX-2 targeted photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Coordination Complexes; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Indomethacin; Iridium; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Nude; Molecular Structure; Photochemotherapy; Photosensitizing Agents; Rhodamines; Structure-Activity Relationship | 2021 |
Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Chlorambucil; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Iridium; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Nude; Molecular Structure; Nanoparticles; Organometallic Compounds; Prodrugs; Rats; Small Molecule Libraries; Surface-Active Agents | 2014 |